-inc-logo-1200x675.png){kind=logo}
Shares of WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) saw an uptick in trading volume on Friday . 923,952 shares changed hands during mid-day trading, an increase of 1,206% from the previous session’s volume of 70,769 shares.The stock last traded at $8.55 and had previously closed at $8.33.
WuXi Biologics (Cayman) Price Performance
The business’s fifty day simple moving average is $8.66 and its 200-day simple moving average is $8.96.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
- Palomar’s High-Risk Insurance Strategy Is Paying Off Big
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
